ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 200 project topics
Cancer Epigenome Database with Drug-Target Integration
A comprehensive, curated SaaS database integrating epigenomic signatures with known cancer drug mechanisms and clinical outcomes. Drives revenue through licensing fees, API access for biotech platforms, and partnerships with oncology research organizations.
Cancer Epigenomics Drug Development Services Click to view more details →
Non-Coding RNA Regulation Analysis Service Platform
A specialized service platform analyzing epigenetic regulation of miRNAs, lncRNAs, and sncRNAs in cancer contexts to identify druggable nodes. Monetizes through project-based fees and retainer contracts with drug discovery programs targeting RNA regulation.
Cancer Epigenomics Drug Development Services Click to view more details →
Clinical Epigenetic Biomarker Validation Testing Service
A CLIA-certified laboratory service validating epigenetic biomarkers for cancer patient stratification and companion diagnostic development. Generates revenue through per-sample analysis fees and exclusive biomarker licensing agreements with pharmaceutical manufacturers.
Cancer Epigenomics Drug Development Services Click to view more details →
CRISPR Epigenetic Modulator Screening Platform
A proprietary high-throughput screening platform testing CRISPR-based epigenetic modulators against cancer cell line panels with functional readouts. Delivers revenue through research service contracts and collaboration fees with biotech companies developing next-generation epigenetic therapeutics.
Cancer Epigenomics Drug Development Services Click to view more details →
Tumor Microenvironment Epigenetic Profiling Service
A multi-omics service analyzing epigenetic states across tumor and immune cell populations to identify immune-epigenetic vulnerabilities. Monetizes through project fees from immuno-oncology programs and partnerships with checkpoint inhibitor developers.
Cancer Epigenomics Drug Development Services Click to view more details →
Real-Time Epigenetic Drug Response Monitoring Platform
A liquid biopsy-integrated SaaS platform tracking epigenetic modifications in circulating tumor DNA to predict and monitor drug response in real-time. Generates recurring revenue through per-patient monitoring subscriptions and clinical trial partnerships with pharmaceutical sponsors.
Cancer Epigenomics Drug Development Services Click to view more details →
DNA Methylation Biomarker SaaS for Personalized Nutrition
A cloud-based platform that analyzes DNA methylation patterns to identify nutritional deficiencies and optimal micronutrient absorption profiles for individual consumers. This enables nutritional supplement companies and wellness brands to deliver precision product recommendations, increasing customer retention and premium pricing power by 40-60%.
Epigenomics for Precision Nutrition Platforms Click to view more details →
Histone Modification Analysis Tool for Nutrient Response Prediction
A commercial software tool that maps histone acetylation and methylation patterns to predict how individuals'' bodies will respond to specific dietary interventions and supplementation protocols. This allows functional medicine practitioners and telehealth platforms to upsell advanced testing services and create subscription-based personalized nutrition plans worth $500-$2000 annually per client.
Epigenomics for Precision Nutrition Platforms Click to view more details →
Chromatin Accessibility Profiling Platform for Dietary Optimization
A proprietary epigenomic assessment service that uses ATAC-seq data to determine which nutritional pathways are most accessible and responsive in an individual''s cells. Nutrition brands leverage this technology to justify premium product positioning and create defensible claims about personalized efficacy, supporting 25-35% margin improvement.
Epigenomics for Precision Nutrition Platforms Click to view more details →
Metabolic Gene Expression Monitoring Dashboard for Wellness Apps
An embeddable SaaS dashboard that tracks epigenetic changes in metabolic genes in real-time through consumer wearables and periodic biosampling to monitor nutrition plan effectiveness. Wellness platforms monetize this through tiered subscriptions ($15-$50/month) and partnership revenue with nutritional product manufacturers seeking consumer insights.
Epigenomics for Precision Nutrition Platforms Click to view more details →
Nutrient-Gene Interaction Mapping Engine for Clinical Nutrition
A B2B2C platform that integrates epigenomic data with nutrient bioavailability algorithms to create clinically-validated nutrition plans for chronic disease management and preventive health. This generates recurring revenue through healthcare system licensing ($100K-$500K annually) and direct-to-consumer personalized supplement sales with 60%+ gross margins.
Epigenomics for Precision Nutrition Platforms Click to view more details →
Non-Coding RNA Expression Profiling for Metabolic Health Products
A commercial testing service that profiles microRNA and long non-coding RNA signatures to identify metabolic dysfunction and optimal nutritional interventions for weight management and metabolic syndrome. This positions premium nutrition brands to charge $400-$800 per comprehensive epigenomic assessment plus ongoing personalized protocol subscriptions.
Epigenomics for Precision Nutrition Platforms Click to view more details →